SEAN SU: Open Payments
NPI 1346211414 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,958 in 126 payments from 12 companies in 2025. Trend: 2023 $3,018 · 2024 $2,162 · 2025 $2,958
Food & beverage: $2,958
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 36 | $726 |
| Axsome Therapeutics, Inc. | 13 | $465 |
| Alkermes, Inc. | 13 | $358 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $314 |
| Otsuka America Pharmaceutical, Inc. | 8 | $233 |
| Neurocrine BioSciences, Inc. | 11 | $230 |
| ABBVIE INC. | 11 | $173 |
| Vanda Pharmaceuticals Inc. | 5 | $141 |
| Janssen Pharmaceuticals, Inc | 9 | $140 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
Products named: UZEDY, Auvelity, CAPLYTA, REXULTI, INGREZZA, ARISTADA, VRAYLAR, FANAPT.
Industry payments across PA — which companies pay providers there.
